New York State Teachers Retirement System Reduces Position in Danaher Corporation $DHR

New York State Teachers Retirement System lessened its holdings in Danaher Corporation (NYSE:DHR) by 1.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 497,961 shares of the conglomerate’s stock after selling 7,240 shares during the quarter. New York State Teachers Retirement System owned approximately 0.07% of Danaher worth $98,726,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of DHR. White Pine Capital LLC lifted its holdings in shares of Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the period. Boyd Watterson Asset Management LLC OH increased its stake in Danaher by 2.1% in the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares during the period. Worth Financial Advisory Group LLC raised its position in Danaher by 4.6% during the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after buying an additional 53 shares during the last quarter. Howard Capital Management Group LLC lifted its stake in shares of Danaher by 4.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after acquiring an additional 53 shares during the period. Finally, Bruce G. Allen Investments LLC boosted its holdings in shares of Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after acquiring an additional 54 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on DHR. Guggenheim raised their target price on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday. Jefferies Financial Group raised their price target on Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Deutsche Bank Aktiengesellschaft upped their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $249.92.

Danaher Stock Up 1.4%

Shares of NYSE:DHR opened at $238.28 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The firm has a market cap of $168.31 billion, a price-to-earnings ratio of 49.13, a PEG ratio of 4.24 and a beta of 0.89. The stock’s 50-day moving average price is $225.77 and its two-hundred day moving average price is $210.61. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.71 EPS. On average, research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is currently 26.39%.

Insider Transactions at Danaher

In other news, Director Teri List sold 3,298 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. This represents a 66.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,248 shares of company stock valued at $6,609,663 over the last quarter. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.